2BB score and signals
Allogene Therapeutics, Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 59 | Moderate |
| Momentum | 57 | Stable |
| Financial strength | 9 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2017 |
| Employees | 150 |
| 52-week range | $0.99 – $4.46 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.1568 | — | $2,264.00 |
| 2026-08-12 | — | -0.1745 | — | $2,264.00 |
| 2026-05-13 | -0.18 | -0.1942 | $0.00 | $2,264.00 |
| 2026-03-12 | -0.17 | -0.2207 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish